(Q44567169)

4 December 2017

title

Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression (English)

1 reference

4 December 2017

N Sawai

1

1 reference

4 December 2017

D A Persons

2

1 reference

4 December 2017

S Zhou

3

1 reference

4 December 2017

T Lu

4

1 reference

4 December 2017

Brian P Sorrentino

5

1 reference

4 December 2017

language of work or name

1 reference

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

8

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

376-384

1 reference

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Transfer and expression of the human multiple drug resistance gene into live mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

In vivo selection of retrovirally transduced hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Effects of transplantation on the primitive immunohematopoietic stem cell

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Comparison of the protection of cells from antifolates by transduced human dihydrofolate reductase mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900205-3

7 January 2021

10.1016/S1525-0016(03)00205-3

Identifiers

DOI

1 reference

4 December 2017

1 reference